SEC 13F Intelligence

Eidelman Virant Capital / BMY

Eidelman Virant Capital’s Bristol-Myers Squibb Co Position

Does Eidelman Virant Capital own Bristol-Myers Squibb Co (BMY)? Yes — 41.3K shares worth $3M (+2.18% of its 13F portfolio) as of Q3 2022.

Position Value
$3M
Q3 2022
Shares
41.3K
% of Portfolio
+2.18%
Quarters Held
10
currently held

Position History BMY

Reported value by quarter
Q2 ’20: $651,000Q2 ’20Q3 ’20: $567,000Q4 ’20: $479,000Q4 ’20Q1 ’21: $6MQ2 ’21: $6MQ2 ’21Q3 ’21: $5MQ4 ’21: $5MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ2 ’22Q3 ’22: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 202241.3K$3M+2.18%
Q2 202241.3K$3M+2.19%
Q1 202244.0K$3M+1.73%
Q4 202180.7K$5M+1.83%
Q3 202181.8K$5M+1.88%
Q2 202182.7K$6M+2.13%
Q1 202194.9K$6M+2.42%
Q4 20207.7K$479,000+0.21%
Q3 20209.4K$567,000+0.31%
Q2 202011.1K$651,000+0.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eidelman Virant Capital’s full portfolio or all institutional holders of BMY.